GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (STU:GON) » Definitions » Cyclically Adjusted Book per Share

Geron (STU:GON) Cyclically Adjusted Book per Share : €0.78 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Geron Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Geron's adjusted book value per share for the three months ended in Mar. 2024 was €0.537. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.78 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Geron's average Cyclically Adjusted Book Growth Rate was 1.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -2.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -6.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -9.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Geron was 0.40% per year. The lowest was -12.90% per year. And the median was -6.10% per year.

As of today (2024-06-06), Geron's current stock price is €3.663. Geron's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.78. Geron's Cyclically Adjusted PB Ratio of today is 4.70.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Geron was 4.94. The lowest was 0.48. And the median was 1.67.


Geron Cyclically Adjusted Book per Share Historical Data

The historical data trend for Geron's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geron Cyclically Adjusted Book per Share Chart

Geron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.96 0.71 0.76 0.67 0.78

Geron Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 0.76 0.79 0.78 0.78

Competitive Comparison of Geron's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Geron's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Geron's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Geron's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Geron's Cyclically Adjusted PB Ratio falls into.



Geron Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Geron's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.537/131.7762*131.7762
=0.537

Current CPI (Mar. 2024) = 131.7762.

Geron Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.678 100.560 0.888
201409 0.678 100.428 0.890
201412 0.673 99.070 0.895
201503 0.732 99.621 0.968
201506 0.667 100.684 0.873
201509 0.833 100.392 1.093
201512 0.822 99.792 1.085
201603 0.771 100.470 1.011
201606 0.729 101.688 0.945
201609 0.722 101.861 0.934
201612 0.729 101.863 0.943
201703 0.689 102.862 0.883
201706 0.632 103.349 0.806
201709 0.571 104.136 0.723
201712 0.549 104.011 0.696
201803 0.510 105.290 0.638
201806 0.836 106.317 1.036
201809 0.844 106.507 1.044
201812 0.838 105.998 1.042
201903 0.804 107.251 0.988
201906 0.745 108.070 0.908
201909 0.717 108.329 0.872
201912 0.609 108.420 0.740
202003 0.546 108.902 0.661
202006 0.717 108.767 0.869
202009 0.637 109.815 0.764
202012 0.558 109.897 0.669
202103 0.530 111.754 0.625
202106 0.456 114.631 0.524
202109 0.402 115.734 0.458
202112 0.346 117.630 0.388
202203 0.273 121.301 0.297
202206 0.356 125.017 0.375
202209 0.287 125.227 0.302
202212 0.194 125.222 0.204
202303 0.599 127.348 0.620
202306 0.528 128.729 0.540
202309 0.502 129.860 0.509
202312 0.417 129.419 0.425
202403 0.537 131.776 0.537

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Geron  (STU:GON) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Geron's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.663/0.78
=4.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Geron was 4.94. The lowest was 0.48. And the median was 1.67.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Geron Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Geron's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Geron (STU:GON) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (STU:GON) » Definitions » Cyclically Adjusted Book per Share
Traded in Other Exchanges
Address
919 East Hillsdale Boulevard, Suite 250, Foster City, CA, USA, 94404
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses global rights to this drug. the company operates as a single segment, the development of therapeutic products for oncology.

Geron (STU:GON) Headlines

No Headlines